Fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) failed to show noninferiority in comparison with coronary artery bypass grafting (CABG) on the primary composite endpoint in patients with three-vessel coronary artery disease (CAD), according to FAME 3 trial results.